MAX and metastatic neoplasm: In our analyses of risk rate not adjusted for time, we found a significantly increased risk of metastatic disease in patients with pathogenic germline variants in SDHA, SDHB, SDHC, TMEM127, MAX, and FH compared to those with no identified pathogenic variant.